All News

What is the resource Approved Drug Products With Therapeutic Equivalence Evaluations commonly called?

Data from a new analysis reinforces concerns surrounding the detrimental impact the novel osteoporotic therapy romosozumab can have on cardiovascular health.

Many companies are working with health systems to transition patients from the hospital to in-home care as quickly as possible.

Pembrolizumab has been approved by the FDA as a monotherapy for the treatment of patients with recurrent or metastatic cutaneous squamous cell carcinoma.

According to the survey results, not only do a majority of the 500 respondents experience fear of bleeding events, but many of them also avoid or modify activities in order to mitigate their risk.

According to the investigators, payers and employers are increasingly adopting HDHPs in an effort to control rising health care costs.

Although researchers know that HIV enters the brain within 8 days of infection, less is known about whether HIV-infected brain cells can release the virus, letting it migrate from the brain back into the body to infect other tissues.

A recent qualitative study presented a potential explanation for why health system specialty pharmacies often find it difficult to partner with payers.

The trend toward elevating the role of the pharmacy technician makes this an exciting time to join the profession.

Cognitive impairment is extremely common among patients with MS, affecting approximately two-thirds of this patient population.

Pharmacists, being the most accessible health care professionals, have an important role to play in the management of this pandemic.

Orphan Drug Designation given to potential primary mitochondiral myopathies treatment.

The pharmacy department is generally responsible for making prepared syringes to be distributed prior to procedures.

Molecule binds and blocks a previously unknown opioid receptor in the brain, potentially revolutionizing pain, depression, and cancer treatment.

Although some of the largest insurers have waived their cost sharing requirements, employer-sponsored “self-insured” health insurance plans are not required to adhere to these waivers.

The NIA is currently funding more than 230 active clinical trials on AD and related dementias. Of those, more than 100 are nondrug interventions, such as exercise, diet, cognitive training, sleep, or combination therapies.

Researchers looked at the effects of a genetic risk score for developing T2D as an adult on metabolism, measured from blood samples taken from participants in the study when they were aged 8, 16, 18, and 25 years.

Being able to predict life expectancy will help care providers decide which A1c target ranges are the best for each patient with diabetes.

Women diagnosed with breast cancer while breastfeeding may receive treatments that decrease milk production or are contraindicated.

Planning on how to address drug and equipment shortages will be essential to continuing patient care in the coming months.

The dupilumab pen features a hidden needle and single-press auto-injection, along with visual and audio feedback to help with administration.

Three student pharmacists share their experiences adapting to APPE rotations during the COVID-19 pandemic,

After up to 4.8 years of treatment with nusinersen, 100% of children with spinal muscular atrophy (SMA) who were treated pre-symptomatically are still alive.

H2-receptor antagonists, melatonin, and thiamine are some of the adjuvant treatments being evaluated for patients with COVID-19 due to their various immune-enhancing properties and possible antiviral effects.

Insufficient sleep is prevalent among pharmacy students, and college students more generally, with studies showing that many pharmacy students in the didactic portion of the academic curriculum suffer from poor quality sleep.

Oncology drugs have especially fallen victim to chronic shortages, consequently affecting the availability of substitute agents.

Why is this man gaining weight, instead of losing it, while taking a natural supplement?

A phase 2 clinical trial demonstrated that a 2-week course of teplizumab was able to delay the onset of clinical type 1 diabetes by 3 years compared with patients taking a placebo.

The researchers identified 87 articles using the PubMed and PsycINFO databases and the 2017 American Academy of Neurology (AAN) criteria for therapeutic trials.

Vitamin C and zinc are among the adjuvant treatments being evaluated for patients with COVID-19 due to their various immune-enhancing properties and possible antiviral effects.